Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$55.43

0.38 (0.69%)

14:29
10/09/16
10/09
14:29
10/09/16
14:29

Bristol-Myers reports Phase 3 data on Yervoy in melanoma, says boosts survival

Bristol-Myers Squibb announced "superior efficacy" with Yervoy 10 mg/kg versus placebo on all survival endpoints in the Phase 3 trial CA184-029 evaluating stage III melanoma patients who are at high risk of recurrence following complete surgical resection. In the study, Yervoy compared with placebo significantly improved overall survival, a secondary endpoint, with five-year OS rates at 65.4% in the Yervoy group and 54.4% in the placebo group. Distant metastasis-free survival, a secondary endpoint, was also significantly improved versus placebo and had five-year DMFS rates of 48.3% and 38.9% in the Yervoy and placebo groups, respectively. The median DMFS was 48.3 months with Yervoy versus 27.5 months with placebo. In this updated five-year analysis, the recurrence-free survival -- the primary endpoint -- benefit observed previously with Yervoy was maintained. Updated five-year results demonstrated RFS remained significantly longer for Yervoy versus placebo, with a median RFS of 27.6 months versus 17.1 months, respectively. The safety profile remained consistent with the initial analysis, with no new deaths or safety signals. These data were featured during the 2016 European Society for Medical Oncology Congress Press Program and simultaneously published in The New England Journal of Medicine.

  • 09

    Oct

  • 27

    Oct

  • 31

    Oct

  • 06

    Nov

BMY Bristol-Myers
$55.43

0.38 (0.69%)

09/12/16
JEFF
09/12/16
NO CHANGE
Target $57
JEFF
Hold
Jefferies cuts Bristol-Myers price target, upgrades AstraZeneca
Jefferies analyst Jeffrey Holford lowered his price target for Bristol-Myers Squibb (BMY) to $57 from $69 saying the stock is positioned for a "rough mid term ride." The analyst sees a "difficult catalyst" set for Bristol shares with "numerous" upcoming competitor read-outs in non-small cell lung cancer. The market could see worse than expected data from Bristol's CM-026 and CM-568 studies as well as better than expected data from AstraZeneca's (AZN) MYSTIC study and Roche's (RHHBY) Chemo-IO studies in the first half of 2017, Holford tells investors in a research note. He keeps a Hold rating on Bristol and upgraded this morning AstraZeneca to Buy from Hold. Holford prefers Astra for its immunology exposure.
09/20/16
SBSH
09/20/16
NO CHANGE
Target $70
SBSH
Buy
Bristol-Myers price target lowered to $70 from $75 at Citi
In a research note titled "Brace Yourself. Attractive Valuation but No Near-Term Respite.," Citi analyst Andrew Baum lowered his price target for shares of Bristol-Myers Squibb to $70 from $75. The analyst lowered his earnings forecasts by up to 8% to reflect the "limited supportive data" in the non-small cell lung cancer indication. Baum keeps a Buy rating on the shares as he views the valuation as attractive. He points out, however, the near-term news-flow is likely to be negative.
09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.
09/28/16
ROTH
09/28/16
NO CHANGE
Target $23
ROTH
Buy
Nektar price target raised to $23 from $19 at Roth Capital
Roth Capital analyst Michael Higgins raised his price target for Nektar (NKTR) to $23 from $19 after the company and Bristol-Myers (BMY) announced a clinical collaboration to evaluate the combination of the latter's anti-PD-1 antibody, Opdivo, with NKTR-214. The analyst reiterates a Buy rating on Nektar's shares.

TODAY'S FREE FLY STORIES

NGL

NGL Energy Partners

$21.70

0.1 (0.46%)

18:38
04/24/17
04/24
18:38
04/24/17
18:38
Hot Stocks
NGL Energy Partners sees FY18 adjusted EBITDA $500M-$525M »

For FY18, NGL expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGL

NGL Energy Partners

$21.70

0.1 (0.46%)

18:37
04/24/17
04/24
18:37
04/24/17
18:37
Earnings
NGL Energy Partners sees FY17 adjusted EBITDA $380M »

Based upon preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$130.40

0.44 (0.34%)

18:20
04/24/17
04/24
18:20
04/24/17
18:20
Periodicals
Kimberly-Clark priced for perfection, Barron's reports »

Kimberly-Clark reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 31

    May

DKL

Delek Logistics

18:16
04/24/17
04/24
18:16
04/24/17
18:16
Hot Stocks
Delek Logistics raises quarterly cash distribution 1.5% to 69c per share »

Delek Logistics Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

APU

AmeriGas

$45.83

0.04 (0.09%)

18:10
04/24/17
04/24
18:10
04/24/17
18:10
Hot Stocks
AmeriGas raises dividend 1c to 95c »

Directors of AmeriGas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

, MKGAY

Merck KGaA

$37.91

1.2299 (3.35%)

18:08
04/24/17
04/24
18:08
04/24/17
18:08
Hot Stocks
Merck KGaA divests Biosimilars unit to Fresenius »

Merck KGaA (MKGAY) …

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

MKGAY

Merck KGaA

$37.91

1.2299 (3.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCOM

National Commerce

$37.90

0.15 (0.40%)

18:03
04/24/17
04/24
18:03
04/24/17
18:03
Hot Stocks
National Commerce, Patriot bank sign merger agreement »

National Commerce, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

NCOM

National Commerce

$37.90

0.15 (0.40%)

18:02
04/24/17
04/24
18:02
04/24/17
18:02
Earnings
National Commerce reports Q1 EPS 45c, consensus 35c »

Reports Q1 NIM 4.18% vs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

NFLX

Netflix

$143.83

0.96 (0.67%)

, FB

Facebook

$145.47

1.79 (1.25%)

17:58
04/24/17
04/24
17:58
04/24/17
17:58
Periodicals
FCC chairman expected to reveal net neutrality plans Wednesday, WSJ says »

FCC chairman Ajit Pai is…

NFLX

Netflix

$143.83

0.96 (0.67%)

FB

Facebook

$145.47

1.79 (1.25%)

AMZN

Amazon.com

$907.41

8.88 (0.99%)

GOOG

Alphabet

$862.76

19.57 (2.32%)

GOOGL

Alphabet Class A

$878.93

19.98 (2.33%)

CMCSA

Comcast

$38.01

-0.15 (-0.39%)

CMCSK

Comcast

VZ

Verizon

$47.05

-0.2 (-0.42%)

T

AT&T

$40.02

0.09 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 09

    May

  • 16

    May

  • 16

    May

  • 17

    May

  • 22

    May

  • 23

    May

  • 05

    Jun

MSFT

Microsoft

$67.53

1.13 (1.70%)

, GOOG

Alphabet

$862.76

19.57 (2.32%)

17:48
04/24/17
04/24
17:48
04/24/17
17:48
Periodicals
Microsoft possibly eyes education push, 'CloudBook' system, Windows Central says »

Microsoft (MSFT) may be…

MSFT

Microsoft

$67.53

1.13 (1.70%)

GOOG

Alphabet

$862.76

19.57 (2.32%)

GOOGL

Alphabet Class A

$878.93

19.98 (2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 09

    May

  • 22

    May

KMG

KMG Chemicals

$45.09

0.49 (1.10%)

17:47
04/24/17
04/24
17:47
04/24/17
17:47
Hot Stocks
KMG Chemicals to acquire Flowchem for $495M in cash »

KMG announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$45.09

0.49 (1.10%)

17:46
04/24/17
04/24
17:46
04/24/17
17:46
Hot Stocks
Breaking Hot Stocks news story on KMG Chemicals »

KMG Chemicals to acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UIS

Unisys

$11.15

0.2 (1.83%)

, LLNW

Limelight Networks

$2.75

0.1 (3.77%)

17:43
04/24/17
04/24
17:43
04/24/17
17:43
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Unisys…

UIS

Unisys

$11.15

0.2 (1.83%)

LLNW

Limelight Networks

$2.75

0.1 (3.77%)

LXU

LSB Industries

$7.35

0.18 (2.51%)

SLCA

U.S. Silica

$41.55

1.04 (2.57%)

RRC

Range Resources

$27.23

-0.24 (-0.87%)

SANM

Sanmina

$39.95

1.35 (3.50%)

AA

Alcoa

$33.31

1.61 (5.08%)

IDRA

Idera Pharmaceuticals

$2.25

-0.07 (-3.02%)

HUM

Humana

$213.76

0.09 (0.04%)

ICHR

Ichor Holdings

$18.93

0.57 (3.10%)

CVS

CVS Health

$80.05

0.77 (0.97%)

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

CDNS

Cadence Design

$33.48

0.6 (1.82%)

ABX

Barrick Gold

$19.04

-0.19 (-0.99%)

ZION

Zions Bancorp

$41.96

1.11 (2.72%)

CNI

Canadian National

$75.66

0.94 (1.26%)

WHR

Whirlpool

$174.80

3.29 (1.92%)

CTRV

ContraVir Pharmaceuticals

$1.18

-0.23 (-16.31%)

KPTI

Karyopharm

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 02

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 04

    May

  • 09

    May

  • 10

    May

  • 16

    May

  • 18

    May

  • 31

    May

  • 06

    Jun

  • 13

    Jun

  • 25

    Apr

  • 25

    Apr

  • 28

    Apr

NWN

Northwest Natural Gas

$60.45

0.45 (0.75%)

17:43
04/24/17
04/24
17:43
04/24/17
17:43
Hot Stocks
Northwest Natural Gas appoints Frank Burkhartsmeyeras CFO »

NW Natural has hired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

RTN

Raytheon

$156.03

1.99 (1.29%)

17:41
04/24/17
04/24
17:41
04/24/17
17:41
Hot Stocks
Raytheon awarded $111.3M government contract »

Raytheon Co., Integrated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

GABC

German American Bancorp

$33.49

-15.7 (-31.92%)

17:39
04/24/17
04/24
17:39
04/24/17
17:39
Hot Stocks
German American Bancorp raises quarterly dividend to 13c per share »

The company announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRBA

First Bank

$13.35

-0.15 (-1.11%)

17:39
04/24/17
04/24
17:39
04/24/17
17:39
Hot Stocks
First Bank reports Q1 book value per share $7.95 »

Reports Q1 net loan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

GABC

German American Bancorp

$33.49

-15.7 (-31.92%)

17:38
04/24/17
04/24
17:38
04/24/17
17:38
Earnings
German American Bancorp reports Q1 EPS 42c, may not compare to consensus 62c »

First quarter 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICHR

Ichor Holdings

$18.93

0.57 (3.10%)

17:37
04/24/17
04/24
17:37
04/24/17
17:37
Syndicate
Ichor Holdings announces offering of 4.5M ordinary shares for holders »

Ichor Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

FRBA

First Bank

$13.35

-0.15 (-1.11%)

17:37
04/24/17
04/24
17:37
04/24/17
17:37
Earnings
First Bank reports Q1 EPS 17c, consensus 18c »

Reports Q1 revenue $8.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

IDRA

Idera Pharmaceuticals

$2.25

-0.07 (-3.02%)

17:35
04/24/17
04/24
17:35
04/24/17
17:35
Initiation
Idera Pharmaceuticals initiated  »

Idera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

MDSO

Medidata

$63.65

0.65 (1.03%)

17:33
04/24/17
04/24
17:33
04/24/17
17:33
Hot Stocks
Medidata announces expanded partnership with WuXi »

Medidata announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

ARDX

Ardelyx

$12.55

0.05 (0.40%)

17:30
04/24/17
04/24
17:30
04/24/17
17:30
Syndicate
Breaking Syndicate news story on Ardelyx »

Ardelyx files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

AKRX

Akorn

$32.72

-0.19 (-0.58%)

17:30
04/24/17
04/24
17:30
04/24/17
17:30
Hot Stocks
Breaking Hot Stocks news story on Akorn 

Akorn trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$11.37

0.07 (0.62%)

17:30
04/24/17
04/24
17:30
04/24/17
17:30
Hot Stocks
Transocean says contract backlog $10.8B as of April 24, 2017 »

Transocean issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.